Open Access Highly Accessed Research article

A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer

Mitchell Gross*, Celestia Higano, Allan Pantuck, Olga Castellanos, Erica Green, Koo Nguyen and David B Agus

BMC Cancer 2007, 7:142  doi:10.1186/1471-2407-7-142

Article Metrics

4330
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 22 accesses
  • Last 365 days: 442 accesses
  • All time: 4330 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information